E-LIB Suche - Ergebnisse für: Leaf, Andrea

1

Diagnostic and Therapeutic Challenges in a Patient with Syn..:

Wallach, Jonathan ; Youssef, Irini ; Leaf, Andrea.
Current Oncology. 29 (2022) 1 - p. 377-382 , 2022

Link: https://doi.org/10.3390/..

2

An Exceptional Responder to Nivolumab in Metastatic Non-Sma..:

Baseri, Babak ; Samra, Bachar ; Tam, Eric..
Case Reports in Oncological Medicine. 2019 (2019) - p. 1-7 , 2019

Link: https://doi.org/10.1155/..

3

Case report: optimal tumor cytoreduction and octreotide wit..:

Daniels, Lynsey M. ; Khalili, Marian ; Morano, William F....
World Journal of Surgical Oncology. 17 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..

4

Neoadjuvant Concurrent Chemoradiation for Curative Treatmen..:

Chhabra, Arpit ; Schwartz, David ; Leaf, Andrea...
Case Reports in Oncological Medicine. 2014 (2014) - p. 1-4 , 2014

Link: https://doi.org/10.1155/..

5

Tu1542 CREATION OF A MULTI-FACILITY, MULTI-SPECIALTY, DEDIC..:

Abramowitz, Binyamin R. ; Horowitz, Judah ; Schwartz, David L....
Gastroenterology. 164 (2023) 6 - p. S-1408 , 2023

Link: https://doi.org/10.1016/..

6

Immunocheckpoint Inhibitor- (Nivolumab-) Associated Hypereo..:

Singh, Navdeep ; Lubana, Sandeep Singh ; Constantinou, George.
Case Reports in Oncological Medicine. 2020 (2020) - p. 1-5 , 2020

Link: https://doi.org/10.1155/..

7

Phase III Study of Combined Chemohormonal Therapy in Metast..:

Leaf, Andrea N. ; Propert, Kathleen ; Corcoran, Chris...
Medical Oncology. 20 (2003) 2 - p. 137-146 , 2003

Link: https://doi.org/10.1385/..

8

An ECOG Phase II Study of Amonafide in Unresectable or Recu..:

Leaf, Andrea N. ; Neuberg, Donna ; Schwartz, Edward L....
Investigational New Drugs. 15 (1997) 2 - p. 165-172 , 1997

Link: https://doi.org/10.1023/..

9

Diagnostic and Therapeutic Challenges in a Patient with Syn..:

Wallach, Jonathan ; Youssef, Irini ; Leaf, Andrea.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775076/. , 2022

Link: http://www.ncbi.nlm.nih...

10

Diagnostic and Therapeutic Challenges in a Patient with Syn..:

Jonathan Wallach ; Irini Youssef ; Andrea Leaf.
Genitourinary Oncology. , 2022

Link: https://doi.org/10.3390/..

11

Diagnostic and Therapeutic Challenges in a Patient with Syn..:

Jonathan Wallach ; Irini Youssef ; Andrea Leaf.
https://www.mdpi.com/1718-7729/29/1/33. , 2022

Link: https://doi.org/10.3390/..

12

An Exceptional Responder to Nivolumab in Metastatic Non-Sma..:

Babak Baseri ; Bachar Samra ; Eric Tam..
http://dx.doi.org/10.1155/2019/1816472. , 2019

Link: https://doi.org/10.1155/..

13

Case report: optimal tumor cytoreduction and octreotide wit..:

Lynsey M. Daniels ; Marian Khalili ; William F. Morano...
https://doi.org/10.1186/s12957-019-1758-6. , 2019

Link: https://doi.org/10.1186/..

14

Neoadjuvant Concurrent Chemoradiation for Curative Treatmen..:

Arpit Chhabra ; David Schwartz ; Andrea Leaf...
http://dx.doi.org/10.1155/2014/479376. , 2014

Link: https://doi.org/10.1155/..

15

Immunocheckpoint Inhibitor- (Nivolumab-) Associated Hypereo..:

Navdeep Singh ; Sandeep Singh Lubana ; George Constantinou.
http://dx.doi.org/10.1155/2020/7492634. , 2020

Link: https://doi.org/10.1155/..